Citation Impact
Citing Papers
Differential diagnosis of suspected multiple sclerosis: a consensus approach
2008
Defining the clinical course of multiple sclerosis
1996 Standout
Consensus definitions proposed for pediatric multiple sclerosis and related disorders
2007
The natural history of multiple sclerosis:a geographically based study
1999
Increased mRNA Expression of IL‐10 in Mononuclear Cells in Multiple Sclerosis and Optic Neuritis
1995
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis
1997
The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease
2006
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout
Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis
2002
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
2010 Standout
Augmented expression of tumour necrosis factor-α and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis
1996
Back to Central Tolerance
2004 Standout
In vitro study of mediators of inflammation in multiple sclerosis
1989
Serial gadolinium‐enhanced magnetic resonance imaging scans in patients with early, relapsing‐remitting multiple sclerosis: Implications for clinical trials and natural history
1991
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
2001 Standout
The Clinical Course of Multiple Sclerosis During Pregnancy and the Puerperium
1990
Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes
1995 StandoutNobel
HLA-DM polymorphisms do not associate with multiple sclerosis: an association study with analysis of myelin basic protein T cell specificity
1997
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
1993 Standout
Cladribine and progressive MS
2000
T cell receptor γδ repertoire is skewed in cerebrospinal fluid of multiple sclerosis patients: molecular and functional analyses of antigen‐reactive γδ clones
1995
The Clinical Epidemiology of Multiple Sclerosis
2008
Anti‐myelin basic protein and anti‐proteolipid protein specific forms of multiple sclerosis
1994
Nitric oxide as a potential pathological mechanism in demyelination: Its differential effects on primary glial cellsin vitro
1994 StandoutNobel
The Fatigue Severity Scale
1989 Standout
Multiple sclerosis. Updated risks for relatives
1988
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Multiple sclerosis
2008 Standout
Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis
1988
Overview of azathioprine treatment in multiple sclerosis
1991
Prospective study on the relationship between infections and multiple sclerosis exacerbations
2002
Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis
2003
Diagnostic criteria for multiple sclerosis
2001 Standout
New natural history of interferon‐β–treated relapsing multiple sclerosis
2007
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
2006 Standout
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
2000 Standout
Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
1993
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
2000
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
The Mini‐Mental State Examination: A Comprehensive Review
1992 Standout
Chronic progressive multiple sclerosis: Serial magnetic resonance brain imaging over six months
1989
Axonal Transection in the Lesions of Multiple Sclerosis
1998 Standout
Rate of Pregnancy-Related Relapse in Multiple Sclerosis
1998 Standout
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
The diagnosis of primary progressive multiple sclerosis
2003
Systemic Autoimmune Features and Multiple Sclerosis
1998
Age at disability milestones in multiple sclerosis
2006
HLA class II‐associated genetic susceptibility in multiple sclerosis: A critical evaluation
1991
Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis
1992
T cell response to myelin basic protein epitopes in multiple sclerosis patients and healthy subjects
1991
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
2015 Standout
Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids
1995
Multiple Sclerosis
2000 Standout
Epidemiology of Multiple Sclerosis: A Critical Overview
1993
The influence of pregnancy on relapses in multiple sclerosis: a cohort study
1991
Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years
2008
A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis
1992 Standout
Increased transforming growth factor‐β, interleukin‐4, and interferon‐γ in multiple sclerosis
1994
Transcranial Magnetic Stimulation: A Primer
2007 Standout
An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis
2011 Standout
Environmental risk factors in multiple sclerosis aetiology
2004
Relapses and Progression of Disability in Multiple Sclerosis
2000
Magnetic Resonance Imaging in the Assessment of Disease Activity in Multiple Sclerosis
1988
New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes
2003
Protein therapeutics: a summary and pharmacological classification
2007 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Screening for Cognitive Impairment in Multiple Sclerosis
1990
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 Standout
Pregnancy and multiple sclerosis ?a 3-year prospective study
1994
Natural History of Multiple Sclerosis with Childhood Onset
2007
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
2005 Standout
Multiple sclerosis
2002 Standout
Diagnostic criteria for primary progressive multiple sclerosis: a position paper.
2000
Cutting Edge: Antisense Knockdown of Inducible Nitric Oxide Synthase Inhibits Induction of Experimental Autoimmune Encephalomyelitis in SJL/J Mice
1998 StandoutNobel
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
1998 Standout
STUDIES ON THE NATURAL HISTORY OF MULTIPLE SCLEROSIS 6. Clinical and Laboratory Findings at First Diagnosis
1972
EDMUS, a European database for multiple sclerosis.
1992
Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events.
1995
Revised diagnostic criteria for neuromyelitis optica
2006 Standout
The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis.
1995
Multiple sclerosis in Europe
1987
Rating neurologic impairment in multiple sclerosis
1983 Standout
Prevalence of multiple sclerosis in Saskatoon.
1982
Intrathecal Interferon Reduces Exacerbations of Multiple Sclerosis
1981 Science
HLA and the inheritance of multiple sclerosis: linkage analysis of 72 pedigrees.
1980
Multiple Sclerosis
2018 Standout
Prevalence of Multiple Sclerosis in British Columbia
1986
NEUROLOGIC IMPAIRMENT IN MULTIPLE SCLEROSIS AND THE DISABILITY STATUS SCALE
1970
The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study
1994 Standout
Epidemiologic evidence for multiple sclerosis as an infection
1993
ILAE Official Report: A practical clinical definition of epilepsy
2014 Standout
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Pregnancy and multiple sclerosis.
1988
Evidence for Differential Roles for NKG2D Receptor Signaling in Innate Host Defense against Coronavirus-Induced Neurological and Liver Disease
2007 StandoutNobel
Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection
1997 StandoutNobel
A humoral response to oligodendrocyte-specific protein in MS
1999
The clinical course of neuromyelitis optica (Devic’s syndrome)
1999 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Rapid Evolution of RNA Genomes
1982 StandoutScience
A REASSESSMENT OF THE DISTRIBUTION OF MULTIPLE SCLEROSIS
2009
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
1983 Standout
Diagnostic criteria for primary progressive multiple sclerosis: A position paper
2000
Practice parameter: The usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review)
2000
Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide.
1993 StandoutNobel
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
2002
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β
2004
A Population-Based Study of Multiple Sclerosis in Twins
1986 Standout
Neuropathic pain
2007 Standout
Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria.
1995
Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients.
1993
CSF neopterin as marker of disease activity in multiple sclerosis
1987
HLA-linked and unlinked determinants of multiple sclerosis
1982
Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.
1990
Pregnancy and Multiple Sclerosis
1994
Works of Thomas L. Willmon being referenced
PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS
1965